GlassScriptPhysician profile
Seth Holland
NPI 1437646304
$5,539.79
in general payments reported to CMS, 2019-2025
24 companies · $621 in 2025
The $621 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $103 · 2021: $1,595 · 2022: $2,261 · 2023: $693 · 2024: $266 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,638.60 | 2022-2023 | |
| Cdc Medical LLC | $1,200.00 | 2021 | |
| Smith+Nephew, INC. | $703.65 | 2020-2025 | Grafix Pl, Renasys Go V2 Home, Collagenase Santyl |
| Organogenesis INC. | $567.65 | 2023-2025 | Puraply Wound Matrix, Puraply, Apligraf |
| Horizon Therapeutics Plc | $261.23 | 2021-2023 | Krystexxa |
| Nevro Corp. | $173.96 | 2022-2024 | Senza |
| Solventum Corporation | $146.31 | 2025 | Activ.A.C., Promogran Prisma |
| Extremity Medical | $122.72 | 2023 | Io Fix |
| Paratek Pharmaceuticals, INC. | $113.65 | 2022-2025 | Nuzyra |
| Baudax Bio INC. | $100.00 | 2022 | |
| Kerecis Limited | $87.96 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Inari Medical, INC. | $73.73 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bioventus LLC | $70.56 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Paragon 28, INC. | $40.01 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $32.04 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $29.55 | 2022 | |
| Integra Lifesciences Corporation | $28.88 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Access Pro Medical, LLC | $28.35 | 2023 | Matriderm |
| Kci USA, INC. | $25.34 | 2022 | |
| Stryker Corporation | $22.87 | 2023 | Spy-Phi System |
| Trice Medical, INC. | $20.82 | 2022 | |
| Triad Life Sciences INC. | $18.20 | 2022 | |
| Nabriva Therapeutics, Plc | $16.95 | 2022 | |
| Mimedx Group, INC. | $16.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Holland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.